X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (89) 89
clofazimine (56) 56
clofazimine - therapeutic use (55) 55
male (45) 45
female (43) 43
adult (38) 38
clofazimine - adverse effects (38) 38
index medicus (31) 31
animals (28) 28
clofazimine - pharmacology (28) 28
leprosy - drug therapy (26) 26
middle aged (23) 23
pharmacology & pharmacy (21) 21
mice (20) 20
leprosy (19) 19
lamprene (15) 15
aged (14) 14
clofazimine - administration & dosage (14) 14
drug therapy, combination (14) 14
adolescent (13) 13
b663 (12) 12
dapsone - therapeutic use (12) 12
pharmacokinetics (11) 11
treatment outcome (11) 11
tuberculosis (11) 11
clofazimine - pharmacokinetics (10) 10
drug therapy (10) 10
leprostatic agents - therapeutic use (10) 10
care and treatment (9) 9
dermatology (9) 9
infectious diseases (9) 9
mycobacterium leprae - drug effects (9) 9
tropical medicine (9) 9
crystallization (8) 8
macrophages (8) 8
mice, inbred balb c (8) 8
antitubercular agents - therapeutic use (7) 7
biopsy (7) 7
clofazimine - chemistry (7) 7
clofazimine - metabolism (7) 7
dosage and administration (7) 7
drugs (7) 7
immunology (7) 7
medicine (7) 7
pathology (7) 7
pyoderma - drug therapy (7) 7
therapy (7) 7
cancer (6) 6
clarithromycin (6) 6
crystals (6) 6
drug resistance, microbial (6) 6
in-vitro (6) 6
leprostatic agents - adverse effects (6) 6
medicine, research & experimental (6) 6
microbial sensitivity tests (6) 6
microbiology (6) 6
pigmentation disorders - chemically induced (6) 6
research (6) 6
skin ulcer - drug therapy (6) 6
analysis (5) 5
antibiotics (5) 5
article (5) 5
chemotherapy (5) 5
child (5) 5
clofazimine - analogs & derivatives (5) 5
clofazimine - blood (5) 5
dapsone - administration & dosage (5) 5
disease (5) 5
disease models, animal (5) 5
drug combinations (5) 5
drug evaluation (5) 5
drug interactions (5) 5
efficacy (5) 5
ethambutol (5) 5
health aspects (5) 5
infection (5) 5
leprosy - pathology (5) 5
leprosy, lepromatous - drug therapy (5) 5
mycobacterium leprae - isolation & purification (5) 5
mycobacterium tuberculosis - drug effects (5) 5
nanoparticles (5) 5
oncology (5) 5
patient outcomes (5) 5
prednisolone - therapeutic use (5) 5
rifampin (5) 5
risk factors (5) 5
skin diseases - drug therapy (5) 5
aids (4) 4
bacterial infections (4) 4
biology and life sciences (4) 4
cell biology (4) 4
cell division - drug effects (4) 4
clinical trials as topic (4) 4
combination (4) 4
complications and side effects (4) 4
cyclosporine-a (4) 4
dapsone - pharmacology (4) 4
deposition (4) 4
diagnosis (4) 4
drug administration schedule (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biomedical Chromatography, ISSN 0269-3879, 02/2018, Volume 32, Issue 2, pp. e4068 - n/a
An LC–MS/MS method was developed and validated for bioanalysis of clofazimine in human dried blood spot (DBS) samples in support of a clinical study on... 
quantification | remote PK sample collection | dried blood spot sampling | clofazimine | DBS card | LC–MS/MS | CHEMISTRY, ANALYTICAL | METABOLITES | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | VALIDATION | REGIMEN | LC-MS/MS | LC-MS | PLASMA | MULTIDRUG-RESISTANT TUBERCULOSIS | DRUGS | PHARMACOLOGY & PHARMACY | BIOANALYSIS
Journal Article
10/2017, ISBN 1119220750, 2
This chapter provides basic characteristics, FDA‐approved indications, side effects/toxicity, dosage information, drug/food interactions and antimicrobial... 
drug interactions | LAMPRENE | clofazimine | multibacillary leprosy | lepromatous leprosy | antimicrobial therapy | mycobacterial infections
Book Chapter
Journal Article
Journal Article
Journal Article
BIOMEDICA, ISSN 0120-4157, 03/2009, Volume 29, Issue 1, pp. 18 - 24
Introduction. Clofazimine enterophathy is a serious complication of clofazimine when used at high doses for treatment of type 2 lepra or or erythema nodosum... 
acute | drug therapy | LAMPRENE | ABDOMINAL-PAIN | abdomen | DEPOSITION | TROPICAL MEDICINE | B663 | lepromatous leprosy/complications | clofazimine | anti-bacterial agents/adverse effects | erythema nodosum | CRYSTALS
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 01/2000, Volume 24, Issue 1, pp. 129 - 135
Journal Article
ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, ISSN 0066-2070, 06/1993, Volume 29, Issue 4, pp. 155 - 163
The efficacy of clofazimine (Lamprene) was analysed retrospectively in twenty one patients with anoperineal lesions (APL) of Crohn's disease. Clofazimine is... 
CROHNS DISEASE | CLOFAZIMINE | ANOPERINEAL LESIONS | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
Indian Journal of Leprosy, ISSN 0254-9395, 1987, Volume 59, Issue 3, pp. 313 - 314
The authors report 3 cases of temporary generalized lymphoadenopathy directly related to Lamprene (Clofazimine) consumption. It appears that this side effect... 
Clofazimine - therapeutic use | Leprosy - drug therapy | Lymphatic Diseases - chemically induced | Humans | Female | Male | Clofazimine - adverse effects
Journal Article
Leprosy review, ISSN 0305-7518, 06/1981, Volume 52, Issue 2, pp. 135 - 140
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.